Streetbeat News

Price Targets

NUE

JP Morgan analyst Michael Glick has upgraded Nucor (NYSE:NUE) from Underweight to Neutral and announced a price target of $151.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:04 pm

SO

Scotiabank analyst Andrew Weisel has upgraded Southern (NYSE:SO) from Sector Perform to Sector Outperform and announced a price target of $78.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 2:02 pm

C

Oppenheimer analyst Chris Kotowski has maintained an 'Outperform' rating on Citigroup (NYSE:C) and raised the price target from $81 to $82.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:54 pm

ERJ

Citigroup analyst Stephen Trent has upgraded Embraer (NYSE:ERJ) from Neutral to Buy and announced a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:51 pm

PTEN

B of A Securities analyst Chase Mulvehill has upgraded Patterson-UTI Energy (NASDAQ:PTEN) from Neutral to Buy and raised the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:50 pm

JPM

Oppenheimer analyst Chris Kotowski maintains an Outperform rating on JPMorgan Chase (NYSE:JPM) and raises the price target from $215 to $233.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:47 pm

VICI

JMP Securities analyst Mitch Germain maintains a Market Outperform rating on VICI Props (NYSE:VICI), but has lowered the price target from $38 to $34.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:46 pm

MSFT

A significant amount of unusual options activity has been observed for Microsoft (NASDAQ:MSFT), with a split sentiment of 50% bullish and 50% bearish among big-money traders. The targeted price range for Microsoft over the last 3 months has been $315.0 to $380.0. The current price of MSFT is up 1.02% at $331.07. Several experts have given their ratings and price targets for Microsoft, with Citigroup downgrading its action to Buy with a price target of $420.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 1:46 pm

RMD

Oppenheimer analyst Suraj Kalia maintains an Outperform rating on ResMed (NYSE:RMD) but has lowered the price target from $275 to $175.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 1:45 pm

BAC

Bank of America Corporation (NYSE:BAC) is expected to report higher Q3 revenue of $25.14 billion, compared to $23.57 billion in the year-ago period. The company's shares gained 1.3% to trade at $27.10 on Monday. Recent price target changes by analysts include Morgan Stanley cutting the target from $34 to $32, Oppenheimer lowering it from $49 to $48, Piper Sandler cutting it from $28 to $27.5, HSBC initiating coverage with a target of $35, and Wells Fargo cutting it from $43 to $40.

Portfolio Pulse from Lisa Levin

October 16, 2023 | 1:37 pm